Gender bias in clinical research, pharmaceutical marketing, and the prescription of drugs
Bibliographic Data
| ID | 19531181 |
|---|---|
| Authors | Elisa Chilet‐rosell (0000-0002-9091-7255, University of Cuenca, corresponding author), Elisa Chilet-Rosell |
| Year | 2014 |
| Volume | 7 |
| Issue | 1 |
| Pages | 25484-25484 |
| Publication date | 2014-12-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Global Health Action (JOURNAL) |
| Journal identifiers | ISSN: 1654-9716 • E-ISSN: 1654-9880 |
| Publisher | Informa UK Limited (PUBLISHER • GB) |
| DOI | 10.3402/gha.v7.25484 |
| PMID | 25498360 |
| OpenAlex | W2023062238 |
| Language | EN |
| Citations received | 3 |
| References cited | 45 |
This thesis is part of the studies of gender bias in health which together with the paradigm of evidence-based medicine shares the empirical assumption that there are inaccuracies in medical practice, in addition to a lack of rigour and transparency. It worked with the distinction between the concepts of sex and gender and between the concepts of sex-related differences and gender inequalities, in terms of applying a gender perspective in the study design and the subsequent analysis. This PhD review presents the research process conducted in Spain, which can provide an example for future research. Study I described a review of 58 clinical trials (CTs) of etoricoxib to assess its compliance with the Recommendations of Evaluation of Gender Differences in the Clinical Evaluation of Drugs. In Study II, key informants from professions related to different areas in drug development and pharmacovigilance held a working meeting to reach a consensus document on recommendations for the study and evaluation of gender differences in CTs in Spain. In Study III, the websites of the eight best-selling hormone replacement therapy drugs in Spain on Google first page of results were analysed. In Study IV, a logistic regression analysis was performed to compare analgesic prescription by sex in regions with a higher or lower Gender Development Index (GDI) than the Spanish average. Gender biases identified in this thesis limited the legitimacy of medicine, which is not based on the best possible evidence. The results also demonstrate the existence of inequalities between men and women that are not due merely to biological differences, but are gender inequalities stemming from the social differences that exist between both sexes
Alternative medicine · Family medicine · Medical education · Medical prescription · Pharmaceutical industry · Pharmaceutical marketing · Political science · Rigour · Medicine · Pharmaceutical industry and healthcare · Psychology · Sex and Gender in Healthcare · Pharmacology
Genders, sexes, and health
A systematic review of delay in the diagnosis and treatment of tuberculosis
The concepts and principles of equity and health
'E-health'
Hormone Replacement Therapy advertising
Accounting for health of women
Women in advertisements in medical journals
A two way view of gender bias in medicine
A framework to analyse gender bias in epidemiological research
Hormone replacement therapy, cancer, controversies, and women’s health
European Medicines Agency policies for clinical trials leave women unprotected
Cross-national variation of gender differences in adolescent subjective health in Europe and North America
Gender and class as dimensions of smoking behaviour in Britain
The male heart and the female mind
Feminism meets the "new" epidemiologies
Women's status and the health of women and men
| Unique citing works | 3 |
|---|---|
| Citations per year | 0,25 |
| Citation span | 2014 - 2025 (12) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 3 |